x

Posted 06 November, 2023

SELECTIS HEALTH, INC. appointed new CEO

CEO Change detected for ticker OTC:GBCS in a 8-K filed on 06 November, 2023.


  On October 31, 2023, Lance J. Baller tendered his resignation from all positions with the Company, including as Chief Executive Officer, acting principal financial officer and a member of the Board of Directors of Selectis Health, Inc. (the "Company"), effective November 13, 2023 or at such earlier date as the Company finds a replacement.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of SELECTIS HEALTH, INC.
Real Estate/Construction • Healthcare REITs
Selectis Health, Inc. engages in the acquisition, development, leasing, and management of healthcare real estate and provides financing to healthcare providers. It operates through the Real Estate Services and Healthcare Services segments. The company was founded on June 8, 1978 and is headquartered in Greenwood Village, CO.
Market Cap
$9.32M
View Company Details
SELECTIS HEALTH, INC. by TradingView
Relevant filing section
ITEM 5.02 DEPARTURE OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER


On October 31, 2023, Lance J. Baller tendered his resignation from all positions with the Company, including as Chief Executive Officer, acting principal financial officer and a member of the Board of Directors of Selectis Health, Inc. (the "Company"), effective November 13, 2023 or at such earlier date as the Company finds a replacement.


Adam Desmond, a current Board member, has agreed to be appointed Interim Chief Executive Officer. Mr. Desmond's biographical information is included in the Company's Annual Report on Form 10K as of and for the year ended December 31, 2022. Mr. Desmond will be compensated at the same rate as Mr. Baller, namely base salary of $150,000 per year, payable bi-weekly.


The Company will continue its search for a principal financial officer.